Sa1049 Effect of Combination Therapy Peginterferon Alfa-2B and Ribavirin on Prevention of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Normal Aminotransferase Levels

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Faculty Opinions recommendation of Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718521034.793498216 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Older Patients ◽

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy

Journal of the Formosan Medical Association ◽

10.1016/j.jfma.2017.11.008 ◽

2018 ◽

Vol 117 (11) ◽

pp. 1011-1018 ◽

Cited By ~ 4

Author(s):

Kuo-Chin Chang ◽

Yi-Hao Ye ◽

Cheng-Kun Wu ◽

Ming-Tsung Lin ◽

Ming-Chao Tsai ◽

...

Keyword(s):

Risk Factors ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Sustained Response

Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C

Future Virology ◽

10.2217/17460794.2.6.553 ◽

2007 ◽

Vol 2 (6) ◽

pp. 553-563

Author(s):

Frank Yeh ◽

Fredric D Gordon

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

PIN6 CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIVIRAL COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS C ADMINISTERED ACCORDING TO THE NEW GENOTYPESPECIFIC GUIDELINES

Value in Health ◽

10.1016/s1098-3015(10)66023-8 ◽

2004 ◽

Vol 7 (6) ◽

pp. 759-760

Author(s):

U Siebert ◽

G Sroczynski ◽

P Aidelsburger ◽

S Rossol ◽

J Wasem ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Clinical Effectiveness ◽

996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia

Hepatology ◽

10.1016/s0270-9139(03)81034-0 ◽

2003 ◽

Vol 38 ◽

pp. 636-636 ◽

Cited By ~ 25

Author(s):

O SHOBOKSHI ◽

F SEREBOUR ◽

L SKAKNI ◽

N ALJASSER ◽

A TANTAWI ◽

...

Keyword(s):

Saudi Arabia ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Response Rate ◽

Biochemical Response ◽

Genotype 4 ◽

Hepatocellular carcinoma in a long-term sustained virological responder following pegylated-interferon plus ribavirin combination therapy for chronic hepatitis C

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2014.03.1065 ◽

2014 ◽

Vol 21 ◽

pp. 311

Author(s):

E. Gunal ◽

M.K. Celen

Keyword(s):

Pegylated Interferon Plus Ribavirin

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Sustained Virological Responder ◽

Efficacy of Peginterferon alfa-2a and Ribavirin Combination Therapy in Treatment-naive Estonian Patients with Chronic Hepatitis C

Central European Journal of Public Health ◽

10.21101/cejph.a3706 ◽

2012 ◽

Vol 20 (2) ◽

pp. 150-155 ◽

Cited By ~ 5

Author(s):

Vadim Brjalin ◽

Riina Salupere ◽

Tatjana Tallo ◽

Tatiana Kuznetsova ◽

Ljudmilla Priimägi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Treatment Naïve ◽

Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2008.01006.x ◽

2008 ◽

Vol 15 (9) ◽

pp. 659-665 ◽

Cited By ~ 17

Author(s):

T.-M. Scherzer ◽

K. R. Reddy ◽

F. Wrba ◽

H. Hofer ◽

K. Staufer ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C

Effectiveness of peginterferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting

Digestive and Liver Disease ◽

10.1016/s1590-8658(06)80519-0 ◽

2006 ◽

Vol 38 ◽

pp. S192

Author(s):

N. Terreni ◽

G. Mandelli ◽

G. Spinzi ◽

G. Minoli

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Clinic Setting ◽

Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: A report of 9 cases

Hepatology ◽

10.1053/jhep.2003.50107 ◽

2003 ◽

Vol 37 (5) ◽

pp. 1226-1227 ◽

Cited By ~ 49

Author(s):

Maria Buti ◽

Auristela Valdes ◽

Francisco Sanchez-Avila ◽

Rafael Esteban ◽

Yoav Lurie

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Genotype 1 ◽